Gf Fund Management Co. Ltd. Entrada Therapeutics, Inc. Transaction History
Gf Fund Management Co. Ltd.
- $4.26 Trillion
- Q1 2025
A detailed history of Gf Fund Management Co. Ltd. transactions in Entrada Therapeutics, Inc. stock. As of the latest transaction made, Gf Fund Management Co. Ltd. holds 958 shares of TRDA stock, worth $8,746. This represents 0.0% of its overall portfolio holdings.
Number of Shares
958
Previous 785
22.04%
Holding current value
$8,746
Previous $13.6 Million
36.2%
% of portfolio
0.0%
Previous 0.0%
Shares
2 transactions
Others Institutions Holding TRDA
# of Institutions
104Shares Held
27.8MCall Options Held
40.3KPut Options Held
4.1K-
Baker Bros. Advisors LP New York, NY4.87MShares$44.4 Million0.93% of portfolio
-
5 Am Venture Management, LLC San Francisco, CA4.41MShares$40.2 Million33.83% of portfolio
-
Mpm Asset Management LLC Cambridge, MA4.38MShares$40 Million60.89% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD2.9MShares$26.5 Million0.01% of portfolio
-
Janus Henderson Group PLC London, X02.08MShares$19 Million0.02% of portfolio
About Entrada Therapeutics, Inc.
- Ticker TRDA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 31,368,500
- Market Cap $286M
- Description
- Entrada Therapeutics, Inc., a biotechnology company, develops endosomal escape vehicle (EEV) therapeutics for the treatment of multiple neuromuscular diseases. Its endosomal escape vehicle platform develops a portfolio of oligonucleotide, antibody, and enzyme-based programs. The company's lead product candidate is ENTR-601-44, which is in precli...